J. S. Oxford

1.7k total citations · 1 hit paper
43 papers, 1.2k citations indexed

About

J. S. Oxford is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, J. S. Oxford has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in J. S. Oxford's work include Influenza Virus Research Studies (22 papers), Respiratory viral infections research (16 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). J. S. Oxford is often cited by papers focused on Influenza Virus Research Studies (22 papers), Respiratory viral infections research (16 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). J. S. Oxford collaborates with scholars based in United Kingdom, Tanzania and Italy. J. S. Oxford's co-authors include C. W. Potter, G. C. Schild, A. W. Galbraith, G. I. Watson, P. Chakraverty, P. Laing, G. C. Schild, D. K. James, Claire L. Jameson and Adrianus C. M. Boon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Immunology.

In The Last Decade

J. S. Oxford

41 papers receiving 1.1k citations

Hit Papers

DETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MAN 1979 2026 1994 2010 1979 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. S. Oxford United Kingdom 18 1.0k 273 262 195 123 43 1.2k
G. C. Schild United Kingdom 24 1.0k 1.0× 278 1.0× 347 1.3× 214 1.1× 175 1.4× 64 1.5k
Douglas C. Powers United States 22 884 0.9× 618 2.3× 179 0.7× 190 1.0× 115 0.9× 31 1.4k
P. Chakraverty United Kingdom 18 958 0.9× 174 0.6× 287 1.1× 111 0.6× 71 0.6× 32 1.1k
Thomas Francis United States 21 1.1k 1.1× 248 0.9× 440 1.7× 175 0.9× 104 0.8× 54 1.7k
Janet Wells United States 13 830 0.8× 382 1.4× 273 1.0× 238 1.2× 57 0.5× 15 1.1k
Alyson Smith United States 21 638 0.6× 271 1.0× 339 1.3× 367 1.9× 61 0.5× 47 1.4k
E K Cobb United States 13 441 0.4× 397 1.5× 291 1.1× 262 1.3× 99 0.8× 13 1.1k
Niina Ikonen Finland 18 1.1k 1.1× 335 1.2× 406 1.5× 227 1.2× 46 0.4× 56 1.4k
Maria Lattanzi Italy 19 913 0.9× 470 1.7× 432 1.6× 317 1.6× 46 0.4× 37 1.6k
Jin Hyang Kim United States 16 733 0.7× 445 1.6× 233 0.9× 172 0.9× 27 0.2× 35 1.1k

Countries citing papers authored by J. S. Oxford

Since Specialization
Citations

This map shows the geographic impact of J. S. Oxford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. S. Oxford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. S. Oxford more than expected).

Fields of papers citing papers by J. S. Oxford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. S. Oxford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. S. Oxford. The network helps show where J. S. Oxford may publish in the future.

Co-authorship network of co-authors of J. S. Oxford

This figure shows the co-authorship network connecting the top 25 collaborators of J. S. Oxford. A scholar is included among the top collaborators of J. S. Oxford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. S. Oxford. J. S. Oxford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irving, William L., D. K. James, Terence Stephenson, et al.. (2000). Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG An International Journal of Obstetrics & Gynaecology. 107(10). 1282–1289. 178 indexed citations
3.
Donatelli, Isabella, et al.. (1990). Genome and antigenic analysis of influenza A (H3N2) viruses isolated from an epidemic in a closed community of Carmelite nuns. Journal of Medical Virology. 31(2). 112–119. 1 indexed citations
4.
Oxford, J. S., et al.. (1985). Introduction. British Medical Bulletin. 41(4). 307–307. 1 indexed citations
5.
Stuart‐Harris, C. H., et al.. (1983). Problems of antiviral therapy. Academic Press eBooks. 37 indexed citations
6.
Oxford, J. S., Kathleen A. Callow, T. Corcoran, & A. S. Beare. (1982). Plaquing characteristics of influenza A virus recombinants of defined genetic composition. Archives of Virology. 74(2-3). 227–232. 4 indexed citations
7.
Oxford, J. S.. (1981). Chemotherapy of Influenza and Herpes Virus Infections. Journal of the Royal College of Physicians of London. 15(4). 218–224.
8.
Oxford, J. S., et al.. (1981). Frequency of naturally occurring antibody to influenza virus antigenic variants selected in vitro with monoclonal antibody. Journal of Hygiene. 87(2). 185–190. 34 indexed citations
9.
Schild, G. C. & J. S. Oxford. (1979). INHIBITORS OF INFLUENZA VIRUS REPLICATION. British Medical Bulletin. 35(1). 87–91. 8 indexed citations
10.
Potter, C. W. & J. S. Oxford. (1979). DETERMINANTS OF IMMUNITY TO INFLUENZA INFECTION IN MAN. British Medical Bulletin. 35(1). 69–75. 394 indexed citations breakdown →
11.
Jain, Stephan, H.C. Thomas, J. S. Oxford, & Sheila Sherlock. (1978). Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. Journal of Antimicrobial Chemotherapy. 4(4). 367–373. 20 indexed citations
12.
Oxford, J. S., et al.. (1977). Chemotherapy of herpes simplex virus infections. Medical Entomology and Zoology. 5 indexed citations
13.
Oxford, J. S.. (1976). Drug resistance and antiviral agents. Journal of Antimicrobial Chemotherapy. 2(3). 223–224. 6 indexed citations
14.
Oxford, J. S. & J. D. Williams. (1975). Chemotherapy and control of influenza. Journal of Antimicrobial Chemotherapy. 1(4). 3 indexed citations
15.
Oxford, J. S.. (1975). Specific inhibitors of influenza virus replication as potential chemoprophylactic agents. Journal of Antimicrobial Chemotherapy. 1(1). 7–23. 16 indexed citations
16.
Oxford, J. S.. (1975). Inhibition of the Replication of Influenza A and B Viruses by a Nucleoside Analogue (Ribavirin). Journal of General Virology. 28(3). 409–414. 47 indexed citations
17.
Oxford, J. S.. (1975). Effects of l- -D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis. Journal of Antimicrobial Chemotherapy. 1(suppl 4). 71–76. 9 indexed citations
18.
Galbraith, A. W., J. S. Oxford, G. C. Schild, C. W. Potter, & G. I. Watson. (1971). THERAPEUTIC EFFECT OF 1-ADAMANTANAMINE HYDROCHLORIDE IN NATURALLY OCCURRING INFLUENZA A2/HONG KONG INFECTION. The Lancet. 298(7716). 113–115. 31 indexed citations
19.
Galbraith, A. W., J. S. Oxford, G. C. Schild, & G. I. Watson. (1969). Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment.. PubMed. 41(3). 677–82. 46 indexed citations
20.
Oxford, J. S.. (1967). The Growth of Rubella Virus in Small Laboratory Animals. The Journal of Immunology. 98(4). 697–701. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026